Page last updated: 2024-09-03

gefitinib and beta-solamarine

gefitinib has been researched along with beta-solamarine in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (beta-solamarine)	Trials (beta-solamarine)	Recent Studies (post-2010) (beta-solamarine)
5,231	566	2,919	63	2	38

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Han, L; Li, J; Tang, Q; Wang, R; Wang, S; Wang, X; Wu, W; Xu, M; Yang, X; Zhou, Q	1

Other Studies

1 other study(ies) available for gefitinib and beta-solamarine

Article	Year
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer. Carcinogenesis, 2023, 08-18, Volume: 44, Issue:6 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 1; Lung Neoplasms; MicroRNAs; Protein Kinase Inhibitors; RNA, Long Noncoding; Signal Transduction	2023

Article

Year

Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer.

Carcinogenesis, 2023, 08-18, Volume: 44, Issue:6

Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 1; Lung Neoplasms; MicroRNAs; Protein Kinase Inhibitors; RNA, Long Noncoding; Signal Transduction

2023